Nicolas Boissel

48PUBLICATIONS
296CO-AUTHORS
HaematologyChild and adolescent developmentHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Aug 31, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.

|Jul 29, 2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

|May 13, 2026
Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

|Mar 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Mar 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Loïc Vasseur, Matthieu Duchmann, Nicolas Duployez

|Feb 24, 2026
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia.

Nicolas Lecornec, Florence Rabian, Marie-Emilie Dourthe

Pageof 8

Frequent Collaborators

12 joint publications

Rathana Kim

11 joint publications

Philippe Rousselot

10 joint publications

Emmanuelle Clappier

9 joint publications

Yves Chalandon